Publisher
Springer Science and Business Media LLC
Reference59 articles.
1. CDC (Cent. Dis. Control Prev.). 2022. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data—United States and 6 dependent areas, 2020. HIV Surveill Rep 33. https://stacks.cdc.gov/view/cdc/121127/cdc_121127_DS1.pdf.
2. CDC (Cent. Dis. Control Prev.). 2021b. Estimated HIV incidence and prevalence in the United States, 2015–2019. HIV Surveill. Suppl. Rep 26(1). https://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-surveillance-supplementalreport-vol-26-1.pdf.
3. Murchu EO, Marshall L, Teljeur C, Harrington P, Hayes C, Moran P, Ryan M. Oral pre-exposure prophylaxis (PrEP) to prevent HIV: a systematic review and meta-analysis of clinical effectiveness, safety, adherence and risk compensation in all populations. BMJ open. 2022;12(5):e048478.
4. Brooks RA, Landrian A, Nieto O, Fehrenbacher A. Experiences of anticipated and enacted pre-exposure prophylaxis (PrEP) stigma among latino MSM in Los Angeles. AIDS Behav. 2019;23:1964–73.
5. Shrader CH, Stoler J, Arroyo-Flores J, Doblecki-Lewis S, Carrico A, Safren S, Fallon S, Kanamori M. Geographic disparities in availability of spanish-language PrEP services among latino sexual minority men in South Florida. J Immigr Minor Health. 2023;25(2):374–81.